ArticleBMC pharmacology & toxicology2018

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.

Natalie Eaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.